CARDINAL HEALTH INC - Common Stock (CAH)

Historical Holders from Q1 2014 to Q4 2025

Symbol: CAH on NYSE
Type / Class: Equity / Common Stock
Shares outstanding: 238,949,120
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 205,499,840
Holdings value: $32,209,908,292
% of all portfolios: 0.02%
Number of holders: 1,203
Number of buys: 540
Number of sells: 580
Average buys %: +0%
Average sells %: -0.01%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of CARDINAL HEALTH INC - Common Stock (CAH) based on Schedule 13D/G filings

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
BlackRock, Inc.	7.8%		$2,582,660,388		18,774,792		BlackRock, Inc.	31 Jan 2025
BlackRock Portfolio Management LLC	5%	+6%	$1,875,272,694	+$102,944,413	11,947,456	+5.8%	BlackRock Portfolio Management LLC	30 Sep 2025

As of 30 Sep 2025 CARDINAL HEALTH INC - Common Stock (CAH) has 1,203 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 205,499,840 shares of 238,949,120 outstanding shares and own 86% of the company stock as of 30 Sep 2025.

Top 25 institutional shareholders of CARDINAL HEALTH INC - Common Stock (CAH) own 57% of the company based on 13F filings as of 30 Sep 2025

Filer	Ownership	Holdings Value	Nb Shares	Share Change %
BlackRock, Inc.	13%	$4,938,692,215	31,464,655	+3%
VANGUARD GROUP INC	13%	$4,838,053,892	30,823,483	+0.81%
STATE STREET CORP	5.1%	$1,928,682,572	12,287,733	-3%
GEODE CAPITAL MANAGEMENT, LLC	2.7%	$1,013,908,455	6,485,089	+1.5%
WELLINGTON MANAGEMENT GROUP LLP	2.4%	$911,009,966	5,804,090	+153%
FMR LLC	2.3%	$850,729,387	5,420,038	-14%
MORGAN STANLEY	2.2%	$820,950,734	5,230,317	-4.4%
BANK OF AMERICA CORP /DE/	1.5%	$563,921,919	3,592,775	+3.2%
Invesco Ltd.	1.5%	$546,724,207	3,483,207	+15%
NORTHERN TRUST CORP	1.2%	$459,278,772	2,926,088	-2.3%
JPMORGAN CHASE & CO	1.2%	$454,986,109	2,898,738	+15%
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC	1.1%	$394,756,442	2,515,013	-2.5%
VICTORY CAPITAL MANAGEMENT INC	0.96%	$352,164,513	2,284,115	+45%
Legal & General Group Plc	0.89%	$335,669,166	2,138,565	-9%
MILLENNIUM MANAGEMENT LLC	0.83%	$311,475,191	1,984,424	+55%
GOLDMAN SACHS GROUP INC	0.83%	$310,406,351	1,977,614	+24%
PRICE T ROWE ASSOCIATES INC /MD/	0.82%	$308,851,000	1,967,697	+21%
BNP PARIBAS FINANCIAL MARKETS	0.82%	$307,131,323	1,956,749	0%
Holocene Advisors, LP	0.81%	$302,331,643	1,926,170	+141%
Man Group plc	0.67%	$251,975,579	1,605,349	+26%
BARCLAYS PLC	0.66%	$248,658,229	1,584,214	+109%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	0.65%	$243,656,385	1,552,347	+2%
AMERIPRISE FINANCIAL INC	0.61%	$228,466,974	1,455,196	+33%
Bank of New York Mellon Corp	0.6%	$226,163,427	1,440,898	-2.2%
Qube Research & Technologies Ltd	0.58%	$215,676,068	1,374,083	-3.2%

Institutional Holders of CARDINAL HEALTH INC - Common Stock (CAH) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q4	181,966	$37,394,044	-$3,278,298			$205.50	12
2025 Q3	205,499,840	$32,209,908,292	+$33,285,710	$283,145,152	$334,366,215	$156.96	1,203
2025 Q2	204,989,696	$34,414,795,368	+$96,702,646	$308,693,232	$331,898,162	$168.00	1,238
2025 Q1	205,242,688	$28,260,366,846	-$605,534,362	$389,891,564	$281,967,893	$137.77	1,136
2024 Q4	209,672,106	$24,807,217,111	-$299,782,897	$199,408,703	$231,594,599	$118.27	1,089
2024 Q3	210,509,139	$23,263,375,433	-$364,012,824	$107,650,115	$213,438,763	$110.52	1,008
2024 Q2	212,798,556	$20,916,059,715	-$313,233,525	$86,128,320	$164,961,296	$98.32	1,000
2024 Q1	216,051,956	$24,163,995,719	+$507,609,218	$129,736,860	$208,727,070	$111.90	1,046
2023 Q4	211,939,329	$21,372,855,862	-$326,674,788	$253,119,951	$190,720,418	$100.80	1,029
2023 Q3	214,756,883	$18,664,651,813	-$364,982,333	$170,922,534	$220,080,018	$86.82	940
2023 Q2	216,659,526	$20,491,930,293	-$189,998,281	$211,106,094	$300,612,450	$94.57	937
2023 Q1	221,321,764	$16,723,399,474	-$185,967,683	$99,065,450	$264,172,400	$75.50	896
2022 Q4	224,671,560	$17,276,898,533	-$840,696,142	$139,880,802	$175,704,213	$76.87	918
2022 Q3	235,571,453	$15,736,821,673	+$177,056,692	$143,045,228	$242,385,000	$66.68	825
2022 Q2	232,761,917	$12,190,007,665	+$34,056,411	$52,587,000	$96,442,000	$52.27	775
2022 Q1	233,502,904	$13,258,180,269	-$48,302,923	$126,582,000	$165,134,000	$56.70	763
2021 Q4	234,259,829	$12,074,000,131	-$400,055,103	$133,593,000	$196,388,000	$51.49	759
2021 Q3	241,518,462	$11,958,032,302	-$189,402,923	$112,307,000	$114,849,000	$49.46	727
2021 Q2	245,102,774	$13,999,099,788	+$42,471,161	$99,989,000	$170,836,000	$57.09	770
2021 Q1	243,725,922	$14,811,693,023	-$127,512,735	$77,780,000	$102,564,000	$60.75	783
2020 Q4	246,487,715	$13,207,490,966	-$47,431,897	$114,375,000	$91,379,000	$53.56	761
2020 Q3	248,194,162	$11,657,416,192	-$188,022,365	$114,887,000	$98,289,000	$46.95	723
2020 Q2	251,005,590	$13,101,812,951	+$62,158,862	$108,616,000	$120,271,000	$52.19	751
2020 Q1	249,457,377	$11,973,500,753	-$377,116,592	$100,660,000	$59,982,000	$47.94	700
2019 Q4	257,708,483	$13,039,312,900	-$299,685,598	$127,816,000	$109,574,000	$50.58	696
2019 Q3	263,058,388	$12,421,807,700	-$154,561,931	$128,008,000	$82,952,000	$47.19	646
2019 Q2	266,301,732	$12,549,277,578	+$112,663,414	$104,119,000	$77,372,000	$47.10	670
2019 Q1	266,393,534	$12,834,915,906	+$252,492,907	$56,992,000	$73,914,000	$48.15	681
2018 Q4	261,154,455	$11,654,601,270	-$346,197,680	$59,565,000	$101,039,000	$44.60	696
2018 Q3	269,053,754	$14,526,491,214	-$313,915,450	$69,858,000	$61,132,000	$54.00	674
2018 Q2	275,052,600	$13,431,885,876	-$812,897,126	$72,923,000	$40,973,000	$48.83	699
2018 Q1	288,649,333	$18,091,853,301	+$335,240,339	$63,595,000	$60,268,000	$62.68	729
2017 Q4	283,389,982	$17,364,246,502	+$63,286,907	$79,136,000	$50,990,000	$61.27	712
2017 Q3	281,127,333	$18,811,937,959	+$39,929,155	$52,586,000	$43,485,000	$66.92	700
2017 Q2	279,781,543	$21,801,515,155	+$216,562,861	$28,052,000	$58,418,000	$77.92	739
2017 Q1	277,112,823	$22,595,266,858	+$1,449,785,019	$35,458,000	$43,123,000	$81.55	758
2016 Q4	281,539,068	$20,271,420,850	+$253,260,316	$32,150,000	$44,744,000	$71.97	768
2016 Q3	276,212,521	$21,447,178,799	-$198,573,615	$65,608,000	$85,747,000	$77.70	764
2016 Q2	277,512,634	$21,660,605,322	-$34,301,853	$27,592,000	$49,113,000	$78.01	801
2016 Q1	277,508,153	$22,736,594,914	-$445,958,665	$38,311,000	$35,153,000	$81.95	784
2015 Q4	282,260,693	$25,199,053,280	-$446,903,454	$37,528,000	$57,748,000	$89.27	779
2015 Q3	286,505,487	$22,010,069,378	+$116,316,606	$71,822,000	$38,143,000	$76.82	751
2015 Q2	286,508,684	$23,968,072,171	-$91,304,996	$35,677,000	$39,543,000	$83.65	758
2015 Q1	287,672,722	$25,956,329,772	+$334,462,478	$29,426,000	$38,119,000	$90.27	727
2014 Q4	284,190,307	$22,949,941,596	-$643,355,007	$81,523,000	$31,375,000	$80.73	699
2014 Q3	291,369,100	$21,829,404,024	-$101,093,684	$50,748,000	$43,700,000	$74.92	631
2014 Q2	292,855,276	$20,082,090,867	+$125,635,349	$60,246,000	$54,223,000	$68.56	632
2014 Q1	290,975,888	$20,358,912,922	-$308,239,818	$43,242,000	$54,428,000	$69.98	640